Dicloxacillin sodium capsules are indicated for the treatment of infections caused by penicillinase-producing staphylococci, which have demonstrated susceptibility to the drug.
Clinicians using Real-Time Prescription Benefit saw prescription pickup rates that were 3.2% points higher than those who did not use the service, according to a study by Surescripts.
Comments to the Centers for Medicare & Medicaid Services call for enforcement of electronic prescribing of controlled substances requirements no later than Jan. 1, 2023.